South African-based vaccine manufacturing firm, Biovac has received funding from France to assist in its development of an oral cholera vaccine. It has also signed two agreements with multinational drug firms.

It comes as stakeholders attend the Global Forum for Vaccine Sovereignty and Innovation along with the African Union and Gavi in France. Thami Ngubeni spoke to Morena Makhoana, Biovac CEO...

South African-based vaccine manufacturing firm, Biovac has received funding from France to assist in its development of an oral cholera vaccine. It has also signed two agreements with multinational drug firms.
It comes as stakeholders attend the Global Forum for Vaccine Sovereignty and Innovation along with the African Union and Gavi in France. Thami Ngubeni spoke to Morena Makhoana, Biovac CEO...

In-depth financial issues, profiling of African businesses doing well internationally, stocks & market updates.

In-depth financial issues, profiling of African businesses doing well internationally, stocks &amp; market updates.

Advertisement